RNVA Pengajuan SEC - Rennova Health, Inc.- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

CIK

931059

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Rennova Health, Inc.

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

February 14, 2025	EX-10.76	Promissory Note between InnovaQor, Inc. (Borrower) and Rennova Health, Inc. (Holder), dated December 31, 2023. (2) Exhibit 10.76 PROMISSORY NOTE $3,000,000 December 31, 2023 FOR VALUE RECEIVED the undersigned, InnovaQor, Inc. (the “Borrower” or “Company”), a corporation organized under the laws of the state of Nevada, hereby promises to pay to the order of Rennova Health, Inc. (the “Holder” or “Rennova”), a corporation organized under the laws of the state of Delaware, the principal amount of Three Million dol
February 14, 2025	EX-10.75	Extension, dated August 9, 2023, of the Promissory Note between InnovaQor, Inc. and Rennova Health, Inc. (2) Exhibit 10.75 Rennova Health, Inc. 400 South Australian Avenue Suite 800 West Palm Beach, FL 33401 The undersigned parties agree to the following modifications to that Promissory Note, dated December 31, 2022 and attached as Exhibit A. ● The Maturity Date (as defined) shall be changed from June 30, 2023 to December 31, 2023 ● Additional interest at a rate of 5% shall be applied to the principal am
February 14, 2025	EX-21	List of Subsidiaries of the Registrant (2) Exhibit 21 List of Subsidiaries Name Jurisdiction of Organization Medytox Institute of Laboratory Medicine, Inc.
February 14, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark one) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 001-35141 RENNOVA HEALT
November 8, 2024	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 4, 2024 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
September 23, 2024	SC 13D/A	FOXO / FOXO Technologies Inc. / Rennova Health, Inc. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* FOXO Technologies Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value (Title of Class of Securities) 351471305 Cusip Number Rennova Health, Inc. 400 S. Australian Avenue Suite 800 West Palm Beach, Florida 33401 Attn: Seamus Lagan (561) 855-1626
September 20, 2024	EX-10.4	Guaranty Agreement, dated as of September 10, 2024, made by FOXO Technologies Inc. and Scott County Community Hospital, Inc. in favor of Rennova Health, Inc. (incorporated by reference to Exhibit 10.4 to Rennova’s Current Report on Form 8-K filed with the SEC on September 20, 2024). Exhibit 10.4 GUARANTY AGREEMENT This GUARANTY AGREEMENT is dated and effective as of September 10, 2024 (as amended, restated or modified from time to time, the “Guaranty”), and is made by FOXO Technologies Inc., a corporation incorporated under the laws of the State of Delaware (“FOXO”), and Scott County Community Hospital, Inc., a corporation incorporated under the laws of the State of Tennessee
September 20, 2024	EX-10.5	Security and Pledge Agreement, dated as of September 10, 2024, by Rennova Community Health, Inc. and Scott County Community Hospital, Inc. in favor of Rennova Health, Inc. (incorporated by reference to Exhibit 10.5 to Rennova’s Current Report on Form 8-K filed with the SEC on September 20, 2024). Exhibit 10.5 SECURITY AND PLEDGE AGREEMENT SECURITY AND PLEDGE AGREEMENT, dated as of September 10, 2024 (this “Agreement”), made by Rennova Community Health, Inc., a Florida corporation, with offices located at 109 Peterson Road, Farragut, Tennessee 37934 (the “Company”), and each of the undersigned direct and indirect Subsidiaries of the Company from time to time, if any (each a “Grantor” and to
September 20, 2024	EX-10.3	Senior Secured Note, dated September 10, 2024, issued by Rennova Community Health, Inc. (incorporated by reference to Exhibit 10.3 to Rennova’s Current Report on Form 8-K filed with the SEC on September 20, 2024). Exhibit 10.3 THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVA
September 20, 2024	8-K	Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 25, 2024 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
September 20, 2024	EX-10.1	Consent and Waiver, dated as of June 25, 2024, among FOXO Technologies Inc., Myrtle Recovery Centers, Inc. and Rennova Health, Inc. Exhibit 10.1
September 20, 2024	EX-10.2	Amended and Restated Stock Exchange Agreement, dated as of September 10, 2024, among FOXO Technologies Inc., Rennova Community Health, Inc., and Rennova Health, Inc. (incorporated by reference to Exhibit 10.2 to Rennova’s Current Report on Form 8-K filed with the SEC on September 20, 2024). Exhibit 10.2 AMENDED AND RESTATED STOCK EXCHANGE AGREEMENT THIS AMENDED AND RESTATED STOCK EXCHANGE AGREEMENT (this “Agreement”) dated as of September 10, 2024, is by and among FOXO Technologies Inc., a Delaware corporation (“FOXO”), Rennova Community Health, Inc., a Florida corporation (“RCHI”), and Rennova Health, Inc., a Delaware corporation (“Rennova” or “RHI”). Each of FOXO, RCHI and RHI is r
September 20, 2024	EX-10.6	Security and Pledge Agreement, dated as of September 10, 2024, by FOXO Technologies Inc. in favor of Rennova Health, Inc. (incorporated by reference to Exhibit 10.6 to Rennova’s Current Report on Form 8-K filed with the SEC on September 20, 2024). Exhibit 10.6 SECURITY AND PLEDGE AGREEMENT SECURITY AND PLEDGE AGREEMENT, dated as of September 10, 2024 (this “Agreement”), made by FOXO Technologies Inc., a Delaware corporation, with offices located at 729 N. Washington Avenue, Suite 600, Minneapolis, Minnesota 55401 (the “GRANTOR”), in favor of the Noteholders (as hereinafter defined). WITNESSETH: WHEREAS, Rennova Community Health, Inc., a Flo
August 5, 2024	EX-4	Registration Rights Agreement, dated June 14, 2024, between FOXO Technologies Inc. and Rennova Health, Inc. * EX-4 3 ex4.htm Exhibit 4
August 5, 2024	SC 13D	FOXO / FOXO Technologies Inc. / Rennova Health, Inc. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* FOXO Technologies Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value (Title of Class of Securities) 351471305 Cusip Number Rennova Health, Inc. 400 S. Australian Avenue Suite 800 West Palm Beach, Florida 33401 Attn: Seamus Lagan (561) 855-1626
August 5, 2024	EX-2	Consent and Waiver, dated as of June 25, 2024, among FOXO Technologies Inc., Myrtle Recovery Centers, Inc., and Rennova Health, Inc.* EX-2 2 ex2.htm Exhibit 2
June 17, 2024	EX-10.2	Stock Exchange Agreement, dated as of June 10, 2024, among FOXO Technologies Inc., Rennova Community Health, Inc. and Rennova Health, Inc. (incorporated by reference to Exhibit 10.2 to Rennova’s Current Report on Form 8-K filed with the SEC on June 17, 2024). Exhibit 10.2 STOCK EXCHANGE AGREEMENT THIS STOCK EXCHANGE AGREEMENT (this “Agreement”) dated as of June 10, 2024, is by and among FOXO Technologies Inc., a Delaware corporation (“FOXO”), Rennova Community Health, Inc., a Florida corporation (“RCHI”), and Rennova Health, Inc., a Delaware corporation (“Rennova” or “RHI”). Each of FOXO, RCHI and RHI is referred to herein individually as a “Party,” or
June 17, 2024	EX-10.1	Stock Exchange Agreement, dated as of June 10, 2024, among FOXO Technologies Inc., Myrtle Recovery Centers, Inc. and Rennova Health, Inc. (incorporated by reference to Exhibit 10.1 to Rennova’s Current Report on Form 8-K filed with the SEC on June 17, 2024). Exhibit 10.1 STOCK EXCHANGE AGREEMENT THIS STOCK EXCHANGE AGREEMENT (this “Agreement”) dated as of June 10, 2024, is by and among Foxo Technologies Inc., a Delaware corporation (“FOXO”), Myrtle Recovery Centers, Inc., a Tennessee corporation (“Myrtle”), and Rennova Health, Inc., a Delaware corporation (“Rennova” or “RHI”). Each of FOXO, Myrtle and RHI is referred to herein individually as a “Party
June 17, 2024	EX-99.1	RENNOVA HEALTH, INC. ANNOUNCES STOCK EXCHANGE AGREEMENTS WITH FOXO TECHNOLOGIES, INC. FOR TWO OPERATING SUBSIDIARIES Exhibit 99.1 RENNOVA HEALTH, INC. ANNOUNCES STOCK EXCHANGE AGREEMENTS WITH FOXO TECHNOLOGIES, INC. FOR TWO OPERATING SUBSIDIARIES WEST PALM BEACH, Fla. (June 17, 2024) – Rennova Health, Inc. (OTC: RNVA) is pleased to announce that it has entered into two stock exchange agreements with FOXO Technologies, Inc., an NYSE American-listed company (“FOXO”)(NYSE American: FOXO). In the first agreement, Re
June 17, 2024	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 10, 2024 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
May 16, 2024	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-35141 CUSIP NUMBER 759757 867 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
April 1, 2024	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-35141 CUSIP NUMBER 759757 867 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 26, 2024	424B3	The date of this prospectus supplement is March 21, 2024 Filed Pursuant to Rule 424(b)(3) Registration No. 333-269077 Prospectus Supplement to prospectus dated May 12, 2023 9,978,100,000 Shares of Common Stock Offered by Selling Stockholders This prospectus supplement is being filed to update, amend and supplement the information included or incorporated by reference in the prospectus dated May 12, 2023, as supplemented on January 10, 2024 (the “Prospec
March 26, 2024	EX-99.1	RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES Exhibit 99.1 RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES WEST PALM BEACH, Fla. (March 26, 2024) — Rennova Health, Inc. (OTC: RNVA) announces that certain Series A, B and C warrants to purchase approximately 403,788,906,644 shares of common stock expired on March 21, 2024, and that on March 20, 2024, the Company and certain institut
March 26, 2024	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 20, 2024 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission Fil
January 11, 2024	424B3	The date of this prospectus supplement is January 10, 2024 Filed Pursuant to Rule 424(b)(3) Registration No. 333-269077 Prospectus Supplement to prospectus dated May 12, 2023 9,978,100,000 Shares of Common Stock Offered by Selling Stockholders This prospectus supplement is being filed to update, amend and supplement the information included or incorporated by reference in the prospectus dated May 12, 2023 (the “Prospectus”), which forms a part of our Regi
November 14, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141 REN
October 31, 2023	EX-10.1	Form of Amendment and Waiver Agreement, dated as of October 25, 2023, among Rennova Health, Inc., Sabby Healthcare Master Fund, Ltd. and Sabby Volatility Warrant Master Fund, Ltd. Exhibit 10.1 FORM OF AMENDMENT AND WAIVER AGREEMENT This Amendment and Waiver Agreement, dated as of October 25, 2023 (this “Agreement”), is among Rennova Health, Inc., a Delaware corporation (“Rennova”), Sabby Healthcare Master Fund, Ltd. (“Sabby Healthcare”) and Sabby Volatility Warrant Master Fund, Ltd. (“Sabby Volatility”). WHEREAS, Rennova, Sabby Healthcare and Sabby Volatility are parties to
October 31, 2023	EX-99.1	RENNOVA HEALTH, INC. ANNOUNCES SIGNIFICANT DEBT RESTRUCTURING Exhibit 99.1 RENNOVA HEALTH, INC. ANNOUNCES SIGNIFICANT DEBT RESTRUCTURING WEST PALM BEACH, Fla. (October 25, 2023) – Rennova Health, Inc. (OTC: RNVA) is pleased to announce a significant debt restructuring with its primary institutional investors. The restructuring extends the maturity date of approximately $8.2 million of secured debt to December 31, 2025, waives historical events of default and
October 31, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 25, 2023 Rennova Health, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 25, 2023 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
August 21, 2023	EX-99.1	RENNOVA HEALTH, INC. PROVIDES UPDATE AFTER FILING 2023 SECOND QUARTER FINANCIAL STATEMENTS Exhibit 99.1 RENNOVA HEALTH, INC. PROVIDES UPDATE AFTER FILING 2023 SECOND QUARTER FINANCIAL STATEMENTS WEST PALM BEACH, Fla. (August 21, 2023) – Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan recently joined Stock Day host Kevin Davis to provide an update after filing the 2023 second quarter financial statements and other information in its Form 10-Q with the SEC. Davis beg
August 21, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 21, 2023 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission Fi
August 21, 2023	EX-99.2	Rennova Health, Inc. (RNVA) Interview CEO Seamus Lagan on Uptick Newswire – August 2023 Exhibit 99.2 Rennova Health, Inc. (RNVA) Interview CEO Seamus Lagan on Uptick Newswire – August 2023 Speakers: Kevin Davis and Seamus Lagan Davis: On today’s show, we’re bringing back a returning company. The name of the company is Rennova Health, Inc. They trade on the OTC Exchange under the ticker symbol ‘RNVA’. With us today is the company’s CEO, Mr. Seamus Lagan. Seamus, welcome back to the po
August 15, 2023	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-35141 CUSIP NUMBER 759757 867 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
August 15, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141 RENNOVA
May 16, 2023	424B3	___________ The date of this prospectus is May 12, 2023 TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(3) Registration No. 333-269077 9,978,100,000 Shares of Common Stock Offered by Selling Stockholders This prospectus relates to the resale, from time to time, by the selling stockholders listed in this prospectus under the section “Selling Stockholders,” of up to 9,978,100,000 shares of common stock, par value $.0001 per share, of Rennova Health, Inc., issuable upon th
May 15, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141 RENNOVA
May 11, 2023	CORRESP	RENNOVA HEALTH, INC. 400 South Australian Avenue, Suite 800 West Palm Beach, Florida 33401 (561) 855-1626 RENNOVA HEALTH, INC. 400 South Australian Avenue, Suite 800 West Palm Beach, Florida 33401 (561) 855-1626 May 11, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Rennova Health, Inc. Registration Statement on Form S-1 File No. 333-269077 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as am
May 9, 2023	EX-FILING FEES	Filing Fee Table (2) Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Rennova Health, Inc.
May 9, 2023	S-1/A	As filed with the Securities and Exchange Commission on May 9, 2023. As filed with the Securities and Exchange Commission on May 9, 2023. Registration No. 333-269077 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Rennova Health, Inc. (Exact name of registrant as specified in its charter) Delaware 8062 68-0370244 (State or other jurisdiction of incorporation
April 24, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 24, 2023 Rennova Health, In UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 24, 2023 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission Fil
April 24, 2023	EX-99.1	RENNOVA HEALTH, INC. PROVIDES UPDATE AFTER FILING 2022 FINANCIAL STATEMENTS Exhibit 99.1 RENNOVA HEALTH, INC. PROVIDES UPDATE AFTER FILING 2022 FINANCIAL STATEMENTS WEST PALM BEACH, Fla. (April 24, 2023) – Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan recently joined Stock Day host Kevin Davis to provide an update after filing the 2022 financial statements and other information in its Form 10-K with the SEC. Davis began the interview by asking Laga
April 24, 2023	EX-99.2	Rennova Health, Inc. (RNVA) Interview CEO Seamus Lagan on Uptick Newswire – April 2023 Exhibit 99.2 Rennova Health, Inc. (RNVA) Interview CEO Seamus Lagan on Uptick Newswire – April 2023 Speakers: Kevin Davis and Seamus Lagan Davis: On today’s show we’re bringing back a returning guest, they were last with us in February of 2023. The name of the company is Rennova Health, Inc. They trade on the OTC Exchange under the ticker symbol ‘RNVA’. With us today is the company’s CEO, Mr. Seam
April 17, 2023	EX-10.100	Promissory Note between InnovaQor, Inc. (Borrower) and Rennova Health, Inc. (Holder) dated December 31, 2022 (2) Exhibit 10.100 PROMISSORY NOTE $1,457,253.00 December 31st 2022 FOR VALUE RECEIVED the undersigned, InnovaQor, Inc. (the “Borrower”), hereby promises to pay to the order of Rennova Health, Inc. (the “Holder or Rennova”), the principal amount of One Million Four Hundred and Fifty Seven Thousand, Two Hundred and Fifty Three dollars on June 30th, 2023 (Maturity date). Whereas. InnovaQor, Inc. is a fu
April 17, 2023	EX-21	List of Subsidiaries of the Registrant (2) Exhibit 21 List of Subsidiaries Name Jurisdiction of Organization Medytox Institute of Laboratory Medicine, Inc.
April 17, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark one) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 001-35141 RENNOVA HEALT
March 31, 2023	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-35141 CUSIP NUMBER 759757 867 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
February 23, 2023	EX-99.2	Rennova Health, Inc. (RNVA) Interview Exhibit 99.2 Rennova Health, Inc. (RNVA) Interview CEO Seamus Lagan on Uptick Newswire – February 2023 Speakers: Everett Jolly and Seamus Lagan Jolly: On today’s show I’m bringing back a returning guest - the last time he was on my show was back in December of last year. I’m talking about no other than Rennova Health, Inc., they trade on the Pink Sheets under the ticker symbol ‘RNVA’. With us toda
February 23, 2023	EX-99.1	RENNOVA HEALTH, INC. PROVIDES UPDATE ON 2022 FINANCIALS AND MYRTLE RECOVERY CENTERS Exhibit 99.1 RENNOVA HEALTH, INC. PROVIDES UPDATE ON 2022 FINANCIALS AND MYRTLE RECOVERY CENTERS WEST PALM BEACH, Fla. (Feb 22, 2023) – Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan recently joined Stock Day host Everett Jolly to provide an update on 2022 financial statements and other activities. Jolly began the interview by referring to the improved previous quarterly rep
February 23, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 22, 2023 Rennova Health, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 22, 2023 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
December 30, 2022	S-1	As filed with the Securities and Exchange Commission on December 30, 2022. As filed with the Securities and Exchange Commission on December 30, 2022. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Rennova Health, Inc. (Exact name of registrant as specified in its charter) Delaware 8062 68-0370244 (State or other jurisdiction of incorporation or organization) (P
December 30, 2022	EX-FILING FEES	Filing Fee Table (2) Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Rennova Health, Inc.
November 23, 2022	8-K	Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 21, 2022 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
November 14, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141 REN
October 20, 2022	EX-99.2	Rennova Health Interview Exhibit 99.2 Rennova Health Interview CEO Seamus Lagan on Uptick Newswire October 2022 Speakers: Everett Jolly and Seamus Lagan Jolly: On today?s show I?m bringing back a returning guest. He was on my show last month in September. I?m talking about no other than Rennova Health, Inc. You can find them on the OTC Markets under the ticker symbol ?RNVA?. With us today is the CEO, who is going to bring
October 20, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 20, 2022 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
October 20, 2022	EX-99.1	RENNOVA HEALTH, INC. PROVIDES Q3 2022 PERFORMANCE UPDATE Exhibit 99.1 RENNOVA HEALTH, INC. PROVIDES Q3 2022 PERFORMANCE UPDATE WEST PALM BEACH, Fla. (Oct 20, 2022) ? Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan recently joined Stock Day host Everett Jolly to provide an update on Q3 2022 performance, and other activities. Jolly began the interview by referring to the previous quarterly reports and asked if the Company expected a
September 23, 2022	8-K	Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 22, 2022 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
September 14, 2022	EX-99.1	RENNOVA HEALTH, INC. PROVIDES BUSINESS UPDATE Exhibit 99.1 RENNOVA HEALTH, INC. PROVIDES BUSINESS UPDATE WEST PALM BEACH, Fla. (Sept 14, 2022) ? Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan joined Stock Day host Everett Jolly to provide an update on the business and future plans. Jolly began the interview by referring to the most recent 10Q filed by the Company and noting the improved net revenues and financial condit
September 14, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 14, 2022 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
September 14, 2022	EX-99.2	RENNOVA HEALTH INTERVIEW CEO SEAMUS LAGAN ON UPTICK NEWSWIRE SEPTEMBER 2022 Exhibit 99.2 RENNOVA HEALTH INTERVIEW CEO SEAMUS LAGAN ON UPTICK NEWSWIRE SEPTEMBER 2022 Speakers: Everett Jolly and Seamus Lagan Jolly: On today?s show I am bringing back a returning guest; he was on my show back in July of this year. I?m talking about no other than Rennova Health, Inc. They trade on the OTC Markets under the ticker symbol ?RNVA? and with us today is the CEO and he will bring us
August 15, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141 RENNOVA
June 16, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 16, 2022 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
June 16, 2022	EX-99.2	Rennova Health Interview Exhibit 99.2 Rennova Health Interview CEO Seamus Lagan on Uptick Newswire June 2022 Speakers: Sever Copley and Seamus Lagan Copley: Welcome to the Stock Day Media Podcast. I am your host Sever Copley, filling in for Everett Jolly. On today?s show, I?m bringing back a returning guest. The last time they were on the show was at the end of April of this year. I?m talking about none other than Rennova
June 16, 2022	EX-99.1	RENNOVA HEALTH, INC. DISCUSSES PROGRESS AND PLANS FOR MENTAL AND BEHAVIORAL HEALTH DIVISION WITH THE STOCK DAY PODCAST Exhibit 99.1 RENNOVA HEALTH, INC. DISCUSSES PROGRESS AND PLANS FOR MENTAL AND BEHAVIORAL HEALTH DIVISION WITH THE STOCK DAY PODCAST WEST PALM BEACH, Fla. (June 16, 2022) ? Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan joined Stock Day host Sever Copley to discuss progress with the business and the Company?s plans to develop a mental and behavioral health division. Copley st
May 23, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141 RENNOVA
May 16, 2022	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-35141 CUSIP NUMBER 759757 867 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
April 27, 2022	EX-99.2	Rennova Health Interview CEO Seamus Lagan on Uptick Newswire April 2022 Exhibit 99.2 Rennova Health Interview CEO Seamus Lagan on Uptick Newswire April 2022 Speakers: Everett Jolly and Seamus Lagan Jolly: On today?s show, I?m bringing back a returning guest. It?s been a little while; the last time he was on the show was back in July of last year. I?m talking about none other than Rennova Health, Inc. You can find them on the OTC Pinks under the ticker symbol RNVA, and
April 27, 2022	EX-99.1	RENNOVA HEALTH, INC. DISCUSSES 2021 FINANCIAL RESULTS AND COMPANY PROGRESS WITH THE STOCK DAY PODCAST Exhibit 99.1 RENNOVA HEALTH, INC. DISCUSSES 2021 FINANCIAL RESULTS AND COMPANY PROGRESS WITH THE STOCK DAY PODCAST WEST PALM BEACH, Fla. (April 27, 2022) ? Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan joined Stock Day host Everett Jolly to discuss its 2021 financial results and provide an update on the business. Jolly started off by referring to the recently filed 2021 fin
April 27, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 27, 2022 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission Fil
April 15, 2022	EX-10.99	Agreement between Alcimede Limited and Rennova Health, Inc. effective as of November 1, 2021 (incorporated by reference to Exhibit 10.99 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on April 15, 2022). Exhibit 10.99 AGREEMENT between Alcimede Limited and Rennova Health, Inc. THIS AGREEMENT is entered into and is effective as of November 1st 2021 between Alcimede Limited, (the ?Company?), a Bahamas based company with its principle place of business at, Suite 104A, Saffrey Square, Bank Lane, PO Box N-9306, Nassau, The Bahamas, and Rennova Health, Inc. (the ?Client?) organized under the laws of the
April 15, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark one) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 001-35141 RENNOVA HEALT
April 15, 2022	EX-21	List of Subsidiaries of the Registrant (2) Exhibit 21 List of Subsidiaries Name Jurisdiction of Organization Medytox Institute of Laboratory Medicine, Inc.
April 7, 2022	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 1, 2022 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
March 31, 2022	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-35141 CUSIP NUMBER 759757 867 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 16, 2022	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 11, 2022 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission Fil
March 16, 2022	EX-3.30	Certificate of Amendment to Certificate of Incorporation of Rennova Health, Inc., filed March 11, 2022 (incorporated by reference to Exhibit 3.30 of the Company’s Current Report on Form 8-K filed with the SEC on March 16, 2022). Exhibit 3.30
March 16, 2022	EX-99.1	RENNOVA HEALTH, INC. COMPLETES REVERSE STOCK SPLIT Exhibit 99.1 RENNOVA HEALTH, INC. COMPLETES REVERSE STOCK SPLIT WEST PALM BEACH, Fla. (March 16, 2022) ? Rennova Health, Inc. (OTC: RNVAD), today announced that effective at 5:00 pm, Eastern Time, on March 15, 2022 (the ?Effective Time?), the Company completed a 1 for 10,000 reverse stock split of its outstanding common stock. The Company?s common stock will open for trading on Wednesday March 16,
March 10, 2022	8-K	Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 9, 2022 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
March 10, 2022	EX-99.1	RENNOVA HEALTH, INC. ANNOUNCES REVERSE STOCK SPLIT Exhibit 99.1 RENNOVA HEALTH, INC. ANNOUNCES REVERSE STOCK SPLIT WEST PALM BEACH, Fla. (March 10, 2022) ? Rennova Health, Inc. (OTC: RNVA), today announced that effective at 5:00 pm, Eastern Time, on March 15, 2022 (the ?Effective Time?), the Company will effect a 1 for 10,000 reverse stock split of its outstanding common stock. The Company?s common stock will open for trading on Wednesday March 16
February 1, 2022	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 31, 2022 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
February 1, 2022	EX-10.1	Form of Securities Purchase Agreement, dated as of January 31, 2022, among Rennova Health, Inc. and the investors signatory thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on February 1, 2022). Exhibit 10.1 FORM OF SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of January 31, 2022, between Rennova Health, Inc., a Delaware corporation (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively, the ?Purchasers?). WHEREAS, subject to the terms and co
December 17, 2021	8-K	Submission of Matters to a Vote of Security Holders, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 15, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
December 16, 2021	DEF 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ? Preliminary Information Statement ? Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)(2)) ? Definitive Information Statement RENNOVA HEALTH, INC. (Name of Regist
December 13, 2021	EX-99.1	RENNOVA HEALTH, INC. OWNED HOSPITAL RECEIVES CRITICAL ACCESS HOSPITAL CERTIFICATION Exhibit 99.1 RENNOVA HEALTH, INC. OWNED HOSPITAL RECEIVES CRITICAL ACCESS HOSPITAL CERTIFICATION WEST PALM BEACH, Fla. (December 3, 2021) ? Rennova Health, Inc. (OTC: RNVA) today announced that the application by its hospital, Scott County Community Hospital, Inc. (DBA Big South Fork) in Oneida, TN, for designation as a Critical Access Hospital (CAH) has been approved by Centers for Medicare and M
December 13, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 3, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
November 26, 2021	PRE 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ? Preliminary Information Statement ? Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)(2)) ? Definitive Information Statement RENNOVA HEALTH, INC. (Name of Regist
November 15, 2021	EX-10.4	Promissory Note, dated August 10, 2021, by Rennova Health, Inc and Scott County Community Hospital, Inc. d/b/a Big South Fork Medical Center (incorporated by reference to Exhibit 10.4 of the Company’s Quarterly Report on Form 10-Q filed with the SEC on November 15, 2021). Exhibit 10.4
November 15, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141 REN
November 15, 2021	EX-10.3	Promissory Note, dated August 10, 2021 by Rennova Health, Inc. and Jellico Medical Center, Inc. (incorporated by reference to Exhibit 10.3 of the Company’s Quarterly Report on Form 10-Q filed with the SEC on November 15, 2021). Exhibit 10.3
November 8, 2021	EX-10.1	Form of Exchange and Amendment Agreement, dated as of November 7, 2021, among Rennova Health, Inc., Christopher Diamantis and the investor signatory thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on November 8, 2021). Exhibit 10.1 FORM OF EXCHANGE AND AMENDMENT AGREEMENT EXCHANGE AND AMENDMENT AGREEMENT (the ?Agreement?) is made as of the 7th day of November 2021, by and between Rennova Health, Inc., a Delaware corporation (the ?Company?) and the investor signatory hereto (the ?Investor?). WHEREAS, the Investor holds certain debt and equity securities of the Company as set forth on Annex I attached hereto (?Exi
November 8, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 5, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
November 8, 2021	EX-3.29	Certificate of Amendment to Certificate of Incorporation of Rennova Health, Inc., filed November 5, 2021 (incorporated by reference to Exhibit 3.29 of the Company’s Current Report on Form 8-K filed with the SEC on November 8, 2021). EXHIBIT 3.29 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF RENNOVA HEALTH, INC. It is hereby certified that: 1. The name of the corporation is Rennova Health, Inc. (the ?Corporation?), a corporation duly organized and existing under the General Corporation Law of the State of Delaware (the ?DGCL?). 2. The Certificate of Incorporation of the Corporation, as amended, is hereby amended
November 8, 2021	EX-3.28	Certificate of Designation for Series P Convertible Redeemable Preferred Stock (incorporated by reference to Exhibit 3.28 of the Company’s Current Report on Form 8-K filed with the SEC on November 8, 2021). Exhibit 3.28 RENNOVA HEALTH, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES P CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Seamus Lagan and Alex Lomosi, do hereby certify that: 1. They are the Chief Executive Officer and President and the Secretary, respectively, of Rennova Health, Inc., a
October 28, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 28, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
October 28, 2021	EX-10.1	Form of Securities Purchase Agreement, dated as of October 28, 2021, among Rennova Health, Inc. and the investors signatory thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on October 28, 2021). EX-10.1 2 ex10-1.htm Exhibit 10.1 FORM OF SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of October 28, 2021, between Rennova Health, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subjec
October 7, 2021	DEF 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ? Preliminary Information Statement ? Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)(2)) ? Definitive Information Statement RENNOVA HEALTH, INC. (Name of Regist
October 4, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 30, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
September 30, 2021	SC 13D/A	RNVA / Rennova Health, Inc. / Diamantis Christopher Eric Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Rennova Health, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 759757875 (CUSIP Number) Christopher E. Diamantis 1143 Glendale Lane Nashville, Tennessee 37204 (Name, Address and Telephone Number of Person A
September 27, 2021	EX-2	Exhibit 2: Lock-Up Agreement, dated May 10, 2021, between Christopher E. Diamantis and Rennova Health, Inc. (filed herewith). Exhibit 2 LOCK-UP AGREEMENT May 10, 2021 Re: Securities Purchase Agreement, dated as of May 10, 2021 (the ?Purchase Agreement?), by and between Rennova Health, Inc.
September 27, 2021	SC 13D	RNVA / Rennova Health, Inc. / Diamantis Christopher Eric Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Rennova Health, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 759757875 (CUSIP Number) Christopher E. Diamantis 1143 Glendale Lane Nashville, Tennessee 37204 (Name, Address and Telephone Number of Person Au
September 22, 2021	PRE 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ? Preliminary Information Statement ? Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)(2)) ? Definitive Information Statement RENNOVA HEALTH, INC. (Name of Regist
September 8, 2021	EX-10.1	Form of Securities Purchase Agreement, dated as of September 7, 2021, among Rennova Health, Inc. and the investors signatory thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on September 8, 2021). Exhibit 10.1 FORM OF SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of September 7, 2021, between Rennova Health, Inc., a Delaware corporation (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively, the ?Purchasers?). WHEREAS, subject to the terms and c
September 8, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 7, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
September 2, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 27, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission Fi
September 2, 2021	EX-10.1	Exchange Agreement, dated as of August 27, 2021, between Rennova Health, Inc. and Christopher Diamantis (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on September 2, 2021). EX-10.1 2 ex10-1.htm Exhibit 10.1 EXCHANGE AGREEMENT EXCHANGE AGREEMENT (the “Agreement”) is made as of the 27th day of August 2021, by and between Rennova Health, Inc., a Delaware corporation (the “Company”), and the Investor signatory hereto (the “Investor”). WHEREAS, the Investor currently owns the number of shares of Series M Redeemable Convertible Preferred Stock, par value $0.01 per share (t
August 16, 2021	EX-99.1	UNAUDITED PRO FORMA CONDENSED FINANCIAL DATA Exhibit 99.1 UNAUDITED PRO FORMA CONDENSED FINANCIAL DATA On June 25, 2021 Rennova Health, Inc. (the ?Company?) sold its subsidiaries, Health Technology Solutions, Inc. (?HTS?) and Advanced Molecular Services, Inc. (?AMSG?) to VisualMED Clinical Solutions Corp. (?VisualMED?). HTS and AMSG held the Company?s software and genetic testing interpretation divisions and were reflected as discontinued op
August 16, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141 RENNOVA
August 16, 2021	8-K/A	Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 25, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission Fi
August 13, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 10, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission Fi
July 21, 2021	CORRESP	RENNOVA HEALTH, INC. 400 South Australian Avenue, Suite 800 West Palm Beach, Florida 33401 (561) 855-1626 RENNOVA HEALTH, INC. 400 South Australian Avenue, Suite 800 West Palm Beach, Florida 33401 (561) 855-1626 July 21, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Rennova Health, Inc. Registration Statement on Form S-1 File No. 333-252995 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as a
July 19, 2021	EX-3.27	Certificate of Amendment to Certificate of Incorporation of Rennova Health, Inc., filed July 14, 2021 (incorporated by reference to Exhibit 3.27 of the Company’s Current Report on Form 8-K filed with the SEC on July 19, 2021). Exhibit 3.27
July 19, 2021	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 14, 2021 Rennova Health, Inc UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 14, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
July 19, 2021	EX-99.1	RENNOVA HEALTH, INC. COMPLETES REVERSE STOCK SPLIT Exhibit 99.1 RENNOVA HEALTH, INC. COMPLETES REVERSE STOCK SPLIT WEST PALM BEACH, Fla. (July 19, 2021) ? Rennova Health, Inc. (OTC: RNVA) (OTC: RNVAW), today announced that effective at 5:00 pm, Eastern Time, on July 16, 2021 (the ?Effective Time?), the Company effected a 1 for 1,000 reverse stock split of its outstanding common stock. The Company?s common stock will open for trading on Monday, Jul
July 16, 2021	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 12, 2021 Rennova Health, Inc UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 12, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
July 13, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 13, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
July 13, 2021	EX-99.1	# # # Exhibit 99.1 RENNOVA HEALTH, INC., DISCUSSES THE COMPLETION OF THE SEPARATION OF ITS SOFTWARE DIVISION AND UPCOMING 10-Q WITH THE STOCK DAY PODCAST WEST PALM BEACH, Fla. (July 13, 2021) ? Rennova Health, Inc. (OTC: RNVA) (OTC: RNVAW), joined Stock Day host Everett Jolly to provide an update on the business and the timing to file the second quarter financial statements. ?Now that the second quarter
July 13, 2021	EX-99.2	Rennova Health Interview CEO Seamus Lagan on Uptick Newswire July 2021 Exhibit 99.2 Rennova Health Interview CEO Seamus Lagan on Uptick Newswire July 2021 Speakers: Everett Jolly and Seamus Lagan Jolly: Before we get started with the show today, I?d like to thank one of our new sponsors, the otcexchange.com. It is the first aggregated news service site. It provides you with all of the information you need to make informed decisions on penny stocks. That is the otcexc
July 12, 2021	EX-99.1	# # # EXHIBIT 99.1 RENNOVA HEALTH, INC. ANNOUNCES REVERSE STOCK SPLIT WEST PALM BEACH, Fla. (July 9, 2021) ? Rennova Health, Inc. (OTC: RNVA) (OTC: RNVAW), today announced that effective at 5:00 pm, Eastern Time, on July 16, 2021 (the ?Effective Time?), the Company will effect a 1 for 1,000 reverse stock split of its outstanding common stock. The Company?s common stock will open for trading on Monday Ju
July 12, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 8, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
July 2, 2021	CORRESP	July 2, 2021 J. THOMAS COOKSON PARTNER Shutts & Bowen LLP 200 South Biscayne Boulevard Suite 4100 Miami, Florida 33131 DIRECT (305) 379-9141 FAX (305) 347-7767 EMAIL [email protected] July 2, 2021 VIA EDGAR Nicholas Lamparski United States Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Rennova Health, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed May 21, 202
July 2, 2021	S-1/A	As filed with the Securities and Exchange Commission on July 2, 2021. As filed with the Securities and Exchange Commission on July 2, 2021. Registration No. 333-252995 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Rennova Health, Inc. (Exact name of registrant as specified in its charter) Delaware 8062 68-0370244 (State or other jurisdiction of incorporation
July 1, 2021	8-K	Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 25, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
June 28, 2021	EX-99.1	# # # Exhibit 99.1 rennova IS pleased to report it has closed THE AGREEMENT TO SEPARATE ITS SOFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS into Visualmed clinical solutions corp. (OTC: VMCS) WEST PALM BEACH, Fla. (June 28. 2021) ? Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (?Rennova? or the ?Company?), an owner and operator of rural hospitals in Tennessee, is please to confirm it has clos
June 28, 2021	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 28, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
June 17, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 15, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
June 17, 2021	DEF 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)(2)) [X] Definitive Information Statement RENNOVA HEALTH, INC. (Name of
June 14, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141 REN
May 24, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 18, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
May 21, 2021	S-1/A	As filed with the Securities and Exchange Commission on May 21, 2021. As filed with the Securities and Exchange Commission on May 21, 2021. Registration No. 333-252995 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Rennova Health, Inc. (Exact name of registrant as specified in its charter) Delaware 8062 68-0370244 (State or other jurisdiction of incorporation
May 21, 2021	CORRESP	May 21, 2021 J. Thomas Cookson Partner Shutts & Bowen LLP 200 South Biscayne Boulevard Suite 4100 Miami, Florida 33131 DIRECT (305) 379-9141 FAX (305) 347-7767 EMAIL [email protected] May 21, 2021 VIA EDGAR Nicholas Lamparski United States Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Rennova Health, Inc. Registration Statement on Form S-1 Filed February 11, 2021 File No. 333
May 17, 2021	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-35141 CUSIP NUMBER 759757 800 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 14, 2021	PRE 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement RENNOVA HEALTH, INC. (Name of
May 11, 2021	EX-10.1	Form of Securities Purchase Agreement, dated as of May 10, 2021, among Rennova Health, Inc. and the investors signatory thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on May 11, 2021). Exhibit 10.1 FORM OF SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of May 10, 2021, between Rennova Health, Inc., a Delaware corporation (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively, the ?Purchasers?). WHEREAS, subject to the terms and condit
May 11, 2021	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 7, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File N
May 11, 2021	EX-3.26	Certificate of Designation for Series O Convertible Redeemable Preferred Stock (incorporated by reference to Exhibit 3.26 of the Company’s Current Report on Form 8-K filed with the SEC on May 17, 2021). Exhibit 3.26 RENNOVA HEALTH, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES O CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Seamus Lagan and Sebastien Sainsbury, do hereby certify that: 1. They are the Chief Executive Officer and President and the Secretary, respectively, of Rennova Health,
April 27, 2021	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 22, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission Fil
April 15, 2021	10-K	Annual Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark one) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 001-35141 RENNOVA H
March 31, 2021	NT 10-K	- SEC FILE NUMBER 001-35141 CUSIP NUMBER 759757 800 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
February 11, 2021	S-1	Power of Attorney for Rennova Health, Inc. (included on the signature page of the Registration Statement filed on February 11, 2021). As filed with the Securities and Exchange Commission on February 11, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Rennova Health, Inc. (Exact name of registrant as specified in its charter) Delaware 8062 68-0370244 (State or other jurisdiction of incorporation or organization) (P
February 5, 2021	8-K	Other Events - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 3, 2021 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
December 10, 2020	EX-99.2	Rennova Health Interview CEO Seamus Lagan on Uptick Newswire December 2020 Exhibit 99.2 Rennova Health Interview CEO Seamus Lagan on Uptick Newswire December 2020 Speakers: Everett Jolly and Seamus Lagan Jolly: On today’s show, I’m bringing back a returning guest; it’s been months since the last time he has been on the show. We’re talking about none other than Rennova Health, Inc. They trade on the OTC markets under the ticker symbol ‘RNVA’, and with us today is the Pres
December 10, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 9, 2020 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
December 10, 2020	EX-99.1	rennova health discusses BUSINESS UPDATE with the stock day podcast Exhibit 99.1 rennova health discusses BUSINESS UPDATE with the stock day podcast WEST PALM BEACH, Fla. (December 9, 2020) – Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), an owner and operator of rural hospitals in Tennessee, announces that Rennova CEO and President of the Company, Seamus Lagan, joined Stock Day host Everett Jolly for a business update. Jolly began th
November 16, 2020	10-Q	Quarterly Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141
October 14, 2020	EX-99.1	Exhibit 99.1 – Joint Filing Agreement pursuant to Rule 13d-1(k).* Exhibit 99.1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Amendment No. 8 to Schedule 13D is filed on behalf of each of the undersigned. The undersigned acknowledge that each shall be responsible for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the complet
October 14, 2020	SC 13D/A	RNVA / Rennova Health, Inc. / Lagan Seamus Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8)* Rennova Health, Inc. (Name of Issuer) Common Stock, $.0001 par value (Title of Class of Securities) 759757 88 3 (CUSIP Number) Seamus Lagan 931 Village Boulevard, Suite 905 West Palm Beach, FL 33409 (561) 855-1626 (Name, Address and Telephone Number of P
September 1, 2020	EX-3.25	Certificate of Designation for Series N Convertible Redeemable Preferred Stock (incorporated by reference to Exhibit 3.25 of the Company’s Current Report on Form 8-K filed with the SEC on September 1, 2020). Exhibit 3.25 RENNOVA HEALTH, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES N CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Seamus Lagan and Sebastien Sainsbury, do hereby certify that: 1. They are the Chief Executive Officer and President and the Secretary, respectively, of Rennova Health,
September 1, 2020	EX-10.1	Form of Exchange, Redemption and Forbearance Agreement, dated as of August 31, 2020, among Rennova Health, Inc., Christopher Diamantis and the investor signatory thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on September 1, 2020). Exhibit 10.1 FORM OF EXCHANGE, REDEMPTION AND FORBEARANCE AGREEMENT EXCHANGE, REDEMPTION AND FORBEARANCE AGREEMENT (the “Agreement”) is made as of the day of August 2020, by and between Rennova Health, Inc., a Delaware corporation (the “Company”) and the investor signatory hereto (the “Investor”). WHEREAS, the Investor holds certain debt and equity securities of the Company as set forth on Annex I
September 1, 2020	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 31, 2020 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission Fi
August 26, 2020	EX-99.1	Exhibit 99.1 – Joint Filing Agreement pursuant to Rule 13d-1(k).* Exhibit 99.1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Amendment No. 7 to Schedule 13D is filed on behalf of each of the undersigned. The undersigned acknowledge that each shall be responsible for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the complet
August 26, 2020	SC 13D/A	RNVA / Rennova Health, Inc. / Lagan Seamus Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7)* Rennova Health, Inc. (Name of Issuer) Common Stock, $.0001 par value (Title of Class of Securities) 759757 88 3 (CUSIP Number) Seamus Lagan 931 Village Boulevard, Suite 905 West Palm Beach, FL 33409 (561) 855-1626 (Name, Address and Telephone Number of P
August 13, 2020	EX-10.1	Voting Agreement and Irrevocable Proxy, dated as of August 13, 2020, by and among Rennova Health, Inc., Seamus Lagan, Alcimede LLC and Christopher Diamantis (incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed with the SEC on August 13, 2020). Exhibit 10.1 VOTING AGREEMENT AND IRREVOCABLE PROXY THIS VOTING AGREEMENT AND IRREVOCABLE PROXY (this “Agreement”) is entered into as of August 13, 2020 (the “Effective Date”), by and among Rennova Health, Inc., a Delaware corporation (the “Company”), Seamus Lagan, an individual shareholder of the Company (“Lagan”), Alcimede LLC, a shareholder of the Company (“Alcimede”), and Christopher Diamantis
August 13, 2020	10-Q	Quarterly Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141 RENN
August 4, 2020	EX-3.24	Certificate of Amendment to Certificate of Incorporation of Rennova Health, Inc. (incorporated by reference to Exhibit 3.24 of the Company’s Current Report on Form 8-K filed with the SEC on August 4, 2020). Exhibit 3.24
August 4, 2020	8-K	Financial Statements and Exhibits, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 30, 2020 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
August 4, 2020	EX-99.1	RENNOVA HEALTH, INC. ANNOUNCES REVERSE STOCK SPLIT Exhibit 99.1 RENNOVA HEALTH, INC. ANNOUNCES REVERSE STOCK SPLIT WEST PALM BEACH, Fla. (August 3, 2020) – Rennova Health, Inc. (OTC: RNVA) (OTC: RNVAW), today announced that effective at 5:00 pm, Eastern Time, on July 31, 2020 (the “Effective Time”), the Company effected a 1 for 10,000 reverse stock split of its outstanding common stock. The Company’s common stock will open for trading on Monday, A
July 24, 2020	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 22, 2020 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
July 24, 2020	EX-99.1	RENNOVA HEALTH, INC. ANNOUNCES REVERSE STOCK SPLIT Exhibit 99.1 RENNOVA HEALTH, INC. ANNOUNCES REVERSE STOCK SPLIT WEST PALM BEACH, Fla. (July 24, 2020) – Rennova Health, Inc. (OTC: RNVA) (OTC: RNVAW), today announced that effective at 5:00 pm, Eastern Time, on July 31, 2020 (the “Effective Time”), the Company will effect a 1 for 10,000 reverse stock split of its outstanding common stock. The Company’s common stock will open for trading on Monday
July 17, 2020	10-Q	Quarterly Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141 REN
July 8, 2020	8-K	Changes in Control of Registrant, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 30, 2020 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
July 8, 2020	EX-10.1	Exchange Agreement, dated as of June 30, 2020, between Rennova Health, Inc. and Christopher Diamantis (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on July 8, 2020). Exhibit 10.1 EXCHANGE AGREEMENT Exchange Agreement, dated as of June 30, 2020 (the “Agreement”), by and between Rennova Health, Inc., a Delaware corporation (“Rennova”), and Christopher Diamantis (“CD”). WHEREAS, over the past number of years CD has provided numerous loans to Rennova and its subsidiaries and paid certain liabilities or bills on behalf of Rennova and its subsidiaries, and continues
June 30, 2020	NT 10-Q	- SEC FILE NUMBER 001-35141 CUSIP NUMBER 759757 800 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
June 27, 2020	10-K	Annual Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark one) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 001-35141 RENNOVA H
June 27, 2020	EX-4.12	Description of the Company’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (incorporated by reference to Exhibit 4.12 to the Company’s Annual Report on Form 10-K filed with the SEC on June 29, 2020). Exhibit 4.12 Description of Rennova Health, Inc.’s Securities The following is a summary of the terms of each class of the securities of Rennova Health, Inc. (the “Company”) that is registered under Section 12 of the Securities Exchange Act of 1934, as amended. Common Stock The following summary of the terms of the Company’s Common Stock, par value $0.0001 per share (the “Common Stock”), is not co
June 16, 2020	EX-3.23	Certificate of Designation for Series M Convertible Preferred Stock (incorporated by reference to Exhibit 3.23 of the Company’s Current Report on Form 8-K filed with the SEC on June 16, 2020). Exhibit 3.23 RENNOVA HEALTH, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES M CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE Delaware GENERAL CORPORATION LAW The undersigned, Seamus Lagan and Sebastien Sainsbury, do hereby certify that: 1. They are the Chief Executive Officer and President and the Secretary, respectively, of Rennova Health,
June 16, 2020	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 9, 2020 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
May 15, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 15, 2020 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
May 14, 2020	NT 10-K	- SEC FILE NUMBER 001-35141 CUSIP NUMBER 759757 800 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 12, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 7, 2020 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File N
May 12, 2020	EX-10.1	Form of Promissory Note, with Evolve Bank & Trust (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on May 12, 2020). Exhibit 10.1
May 8, 2020	DEF 14C	- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)(2)) [X] Definitive Information Statement RENNOVA HEALTH, INC. (Name of
May 8, 2020	S-8 POS	- As filed with the Securities and Exchange Commission on May 8, 2020 Registration No.
May 5, 2020	EX-10.178	Exchange Agreement, dated as of May 5, 2020, between Rennova Health, Inc. and Alcimede LLC Exhibit 10.178 EXCHANGE AGREEMENT Exchange Agreement, dated as of May 5, 2020, by and between Rennova Health, Inc., a Delaware corporation (“Rennova”), and Alcimede LLC, a Delaware limited liability company (“Alcimede”). WHEREAS, on December 23, 2019, Rennova issued to Alcimede 250,000 shares of its Series K Convertible Preferred Stock (the “Series K Preferred Stock”); WHEREAS, shares of the Serie
May 5, 2020	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2020 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File N
May 5, 2020	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 5, 2020 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File N
May 5, 2020	EX-3.22	Certificate of Designation for Series L Convertible Preferred Stock (incorporated by reference to Exhibit 3.22 of the Company’s Current Report on Form 8-K filed with SEC on May 5, 2020). EX-3.22 2 ex3-22.htm Exhibit 3.22 RENNOVA HEALTH, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES L CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE Delaware GENERAL CORPORATION LAW The undersigned, Seamus Lagan and Sebastien Sainsbury, do hereby certify that: 1. They are the Chief Executive Officer and President and the Secretary, respectively, of Rennov
March 30, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 30, 2020 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission Fil
March 12, 2020	PRE 14C	CLRX / PRE 14C - - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement RENNOVA HEALTH, INC. (Name of
March 11, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 11, 2020 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission Fil
February 26, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 26, 2020 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
December 30, 2019	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 30, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
December 30, 2019	10-Q	RNVA / Rennova Health, Inc. 10-Q - Quarterly Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141
December 30, 2019	PRE 14C	RNVA / Rennova Health, Inc. PRE 14C - - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement RENNOVA HEALTH, INC. (Name of
December 27, 2019	EX-10.177	Exchange Agreement, dated as of December 23, 2019, between Rennova Health, Inc. and Alcimede LLC (incorporated by reference to Exhibit 10.177 of the Company’s Current Report on Form 8-K filed with the SEC on December 27, 2019). Exhibit 10.177 EXCHANGE AGREEMENT Exchange Agreement, dated as of December 23, 2019, by and between Rennova Health, Inc., a Delaware corporation (“Rennova”), and Alcimede LLC, a Delaware limited liability company (“Alcimede”). WHEREAS, on July 23, 2018, Rennova issued to Alcimede 250,000 shares of its Series J Convertible Preferred Stock (the “Series J Preferred Stock”); WHEREAS, holders of the Se
December 27, 2019	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 23, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
December 12, 2019	10-Q	RNVA / Rennova Health, Inc. 10-Q - Quarterly Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141 RENN
November 12, 2019	10-Q	RNVA / Rennova Health, Inc. 10-Q - Quarterly Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141 REN
October 30, 2019	EX-99.1	rennova health discusses the timing of filing 2019 quarterly reports to regain compliance, with the stock day podcast rennova health discusses the timing of filing 2019 quarterly reports to regain compliance, with the stock day podcast WEST PALM BEACH, Fla.
October 30, 2019	EX-99.2	Rennova Health Interview CEO Seamus Lagan on Uptick Newswire October 2019 Rennova Health Interview CEO Seamus Lagan on Uptick Newswire October 2019 Speakers: Everett Jolly and Seamus Lagan Jolly: On today’s show, I’m bringing you back a returning guest who was on my show back on the 1st of October of this year.
October 30, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 30, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
October 29, 2019	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 27, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
October 29, 2019	EX-3.21	Certificate of Designation for Series K Convertible Preferred Stock (incorporated by reference to Exhibit 3.21 of the Company’s Current Report on Form 8-K filed with the SEC on October 29, 2019). EX-3.21 2 ex3-21.htm RENNOVA HEALTH, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES K CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE Delaware GENERAL CORPORATION LAW The undersigned, Seamus Lagan and Sebastien Sainsbury, do hereby certify that: 1. They are the Chief Executive Officer and President and the Secretary, respectively, of Rennova Health, Inc
October 25, 2019	SC 13D/A	RNVA / Rennova Health, Inc. / Lagan Seamus Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* Rennova Health, Inc. (Name of Issuer) Common Stock, $.0001 par value (Title of Class of Securities) 759757 80 0 (CUSIP Number) Seamus Lagan 931 Village Boulevard, Suite 905 West Palm Beach, FL 33409 (561) 855-1626 (Name, Address and Telephone Number of P
October 18, 2019	10-K	RNVA / Rennova Health, Inc. 10-K - Annual Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark one) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 0-26824 RENNOVA HEA
October 18, 2019	EX-21	List of Subsidiaries of the Registrant (incorporated by reference to Exhibit 21 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 filed with the SEC on October 21, 2019). Exhibit 21 Name Jurisdiction of Organization Medytox Solutions, Inc. Nevada Scott County Community Hospital, Inc. Tennessee Jamestown TN Medical Center, Inc Tennessee Rennova Health Services TN, Inc. Tennessee Mountain View Physician Practice, Inc. Tennessee Medytox Diagnostics, Inc. Florida Rennova Community Health, Inc. Florida Medytox Institute of Laboratory Medicine, Inc. Florida EPIC Referenc
October 2, 2019	EX-10.176	Form of Promissory Note, dated September 27, 2019 (incorporated by reference to Exhibit 10.176 of the Company’s Current Report on Form 8-K filed with the SEC on October 2, 2019). Form of PROMISSORY NOTE $1,900,000.00 September 27, 2019 THIS PROMISSORY NOTE (as amended, restated, replaced, supplemented or otherwise modified from time to time, this “Note”) is made by RENNOVA HEALTH, INC., a Delaware corporation, having an address at 931 Village Boulevard, Suite 905-196, West Palm Beach, Florida 33409, as maker (“Borrower”), for the benefit of ANTHONY O’KILLOUGH, a natural pe
October 2, 2019	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 27, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
September 3, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 3, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
September 3, 2019	EX-99.2	Rennova Health Interview CEO Seamus Lagan on Uptick Newswire September 2019 Rennova Health Interview CEO Seamus Lagan on Uptick Newswire September 2019 Speakers: Everett Jolly and Seamus Lagan Jolly: On today’s show I’m bringing back a returning guest that was on my show back in June of 2019.
September 3, 2019	EX-99.1	rennova health discusses the intergration of their facilities with the stock day podcast rennova health discusses the intergration of their facilities with the stock day podcast WEST PALM BEACH, Fla.
July 29, 2019	8-K	Entry into a Material Definitive Agreement, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 26, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
July 1, 2019	EX-99.2	Rennova Health Interview CEO Seamus Lagan on Uptick Newswire July 2019 Rennova Health Interview CEO Seamus Lagan on Uptick Newswire July 2019 Speakers: Everett Jolly and Seamus Lagan Jolly: On today’s show, we’re bringing back Rennova Health, Inc.
July 1, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 1, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
July 1, 2019	EX-99.1	rennova chief executive officer seamus lagan joins stock day for business update rennova chief executive officer seamus lagan joins stock day for business update WEST PALM BEACH, Fla.
June 25, 2019	EX-10.175	Form of Bridge Debenture Agreement, dated as of June 24, 2019 (incorporated by reference to Exhibit 10.175 of the Company’s Current Report on Form 8-K filed with the SEC on June 25, 2019). EX-10.175 2 ex10-175.htm FORM OF BRIDGE DEBENTURE AGREEMENT This Bridge Debenture Agreement (this “Agreement”), dated as of June 24, 2019, is made by and among Rennova Health, Inc. (the “Company”) and each of the purchasers signatory hereto (the “Purchasers”). Reference is made to that certain Securities Purchase Agreement, dated as of August 31, 2017 (the “Purchase Agreement”), as amended, by and
June 25, 2019	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 24, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
June 14, 2019	8-K	Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 13, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
June 14, 2019	EX-10.174	Form of Bridge Debenture Agreement, dated as of June 13, 2019 (incorporated by reference to Exhibit 10.174 of the Company’s Current Report on Form 8-K filed with the SEC on June 14, 2019). EX-10.174 2 ex10-174.htm Form OF BRIDGE DEBENTURE AGREEMENT This Bridge Debenture Agreement (this “Agreement”), dated as of June 13, 2019, is made by and among Rennova Health, Inc. (the “Company”) and each of the purchasers signatory hereto (the “Purchaser”). Reference is made to that certain Securities Purchase Agreement, dated as of August 31, 2017 (the “Purchase Agreement”), as amended, by and
June 5, 2019	8-K	Entry into a Material Definitive Agreement, Other Events, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 30, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
May 24, 2019	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 20, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
May 15, 2019	EX-10.173	Form of Bridge Debenture Agreement, dated as of May 12, 2019 (incorporated by reference to Exhibit 10.173 of the Company’s Current Report on Form 8-K filed with the SEC on May 15, 2019). FORM OF BRIDGE DEBENTURE AGREEMENT This Bridge Debenture Agreement (this “Agreement”), dated as of May 12, 2019, is made by and among Rennova Health, Inc.
May 15, 2019	8-K	Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 10, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
April 10, 2019	8-K	Material Modification to Rights of Security Holders, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 8, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
April 10, 2019	EX-99.1	Rennova Health WELCOMES new chief financial officer Rennova Health WELCOMES new chief financial officer WEST PALM BEACH, Fla. (April 9, 2019) – Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW), (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that acquired its third rural hospital in Tennessee in March 2019, announces that its Board of Directors ha
April 5, 2019	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 5, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
April 4, 2019	8-K	Entry into a Material Definitive Agreement, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 31, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission Fil
April 1, 2019	NT 10-K	RNVA / Rennova Health, Inc. SEC FILE NUMBER 001-35141 CUSIP NUMBER 759757 701 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 7, 2019	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 5, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission File
March 7, 2019	EX-99.1	Rennova Health completes purchase of a FIFTY-FOUR bed acute care hospital in Jellico, TN. Rennova Health completes purchase of a FIFTY-FOUR bed acute care hospital in Jellico, TN.
February 28, 2019	8-K	Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 22, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
February 28, 2019	EX-10.173	Asset Purchase Agreement, dated as of February 22, 2019, by and among Jellico Community Hospital, Inc., CarePlus Rural Health Clinic, LLC, Jellico Medical Center, Inc., Community Hospital Corporation and Rennova Health, Inc. (incorporated by reference to Exhibit 10.173 of the Company’s Current Report on Form 8-K filed with the SEC on February 28, 2019). ASSET PURCHASE AGREEMENT BY AND AMONG JELLICO community hospital, INC. AND CAREPLUS RURAL HEALTH CLINIC, LLC AND JELLICO MEDICAL CENTER, INC. AND COMMUNITY HOSPITAL CORPORATION AND RENNOVA HEALTH INC. February 22, 2019 TABLE OF CONTENTS Page 1. PURCHASE OF ASSETS 2 1.1 Assets 2 1.2 Excluded Assets 3 1.3 Assumed Liabilities 4 1.4 Excluded Liabilities 4 1.5 Purchase Price 6 1.6 Net Working Capital,
February 28, 2019	EX-99.1	rennova health signs new DEFINITIVE AGREEMENT to acquire JELLICO COMMUNITY HOSPITAL, TENNESSEE rennova health signs new DEFINITIVE AGREEMENT to acquire JELLICO COMMUNITY HOSPITAL, TENNESSEE WEST PALM BEACH, Fla.
February 20, 2019	EX-99.1	Rennova Health gives financial update on 2018 EX-99.1 2 ex99-1.htm Rennova Health gives financial update on 2018 WEST PALM BEACH, Fla. (February 20, 2019) – Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW), (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that acquired its second rural hospital in Tennessee on June 1, 2018, announces that its
February 20, 2019	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 20, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
February 14, 2019	8-K	Termination of a Material Definitive Agreement, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 8, 2019 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
January 16, 2019	DEF 14C	RNVA / Rennova Health, Inc. DEF 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)(2)) [X] Definitive Information Statement RENNOVA HEALTH, INC. (Name of
January 10, 2019	EX-99.2	Jamestown TN Medical Center, Inc. & Mountain View Physician Practice, Inc. Formerly Known As (F/K/A) HMA Fentress County Hospital, LLC & Jamestown HMA Physician Management, LLC Combined Financial Report March 31, 2018 and 2017 TABLE OF CONTENTS Jamestown TN Medical Center, Inc. & Mountain View Physician Practice, Inc. Formerly Known As (F/K/A) HMA Fentress County Hospital, LLC & Jamestown HMA Physician Management, LLC Combined Financial Report March 31, 2018 and 2017 TABLE OF CONTENTS Page Combined Financial Statements Combined Balance Sheets (unaudited) 1 Combined Statements of Operations (unaudited) 2 Combined Statement of Member’s Def
January 10, 2019	8-K/A	Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 1, 2018 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-03702
January 10, 2019	EX-99.3	UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On June 1, 2018, Rennova Health, Inc.
January 10, 2019	EX-99.1	Jamestown TN Medical Center, Inc. & Mountain View Physician Practice, Inc. Formerly Known As (F/K/A) HMA Fentress County Hospital, LLC & Jamestown HMA Physician Management, LLC Combined Financial Report December 31, 2017 and 2016 TABLE OF CONTENTS Jamestown TN Medical Center, Inc. & Mountain View Physician Practice, Inc. Formerly Known As (F/K/A) HMA Fentress County Hospital, LLC & Jamestown HMA Physician Management, LLC Combined Financial Report December 31, 2017 and 2016 TABLE OF CONTENTS Page Independent Auditor’s Report 1 Combined Financial Statements Combined Balance Sheets 2 Combined Statements of Operations 3 Combined Statement of Me
November 29, 2018	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 29, 2018 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
November 29, 2018	EX-99.1	UPTICK NEWSWIRE’S STOCK DAY PODCAST FEATURES CEO OF RENNOVA HEALTH, INC. TO DISCUSS GROWING REVENUE AND THE PLANNED ACQUISITION OF A THIRD HOSPITAL UPTICK NEWSWIRE’S STOCK DAY PODCAST FEATURES CEO OF RENNOVA HEALTH, INC. TO DISCUSS GROWING REVENUE AND THE PLANNED ACQUISITION OF A THIRD HOSPITAL WEST PALM BEACH, Fla. (November 29, 2018) – Rennova Health, Inc. (OTC: RNVAD), (OTC: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, that r
November 29, 2018	EX-99.2	Rennova Health Interview CEO Seamus Lagan on Uptick Newswire November 2018 EX-99.2 4 ex99-2.htm Rennova Health Interview CEO Seamus Lagan on Uptick Newswire November 2018 Speakers: Everett Jolly and Seamus Lagan Jolly: On today’s show I’m bringing back my returning guest and I tell you what. If this company doesn’t blow up then I’ve got to get out of the business. Because I’ll tell you what, the market cap is only at $270,000 and they’ve got millions and millions of asse
November 26, 2018	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 20, 2018 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
November 26, 2018	EX-10.172	Asset Purchase Agreement, dated as of November 20, 2018, by and among Jellico Community Hospital, Inc., CarePlus Rural Health Clinic, LLC, Jellico Medical Center, Inc., Community Hospital Corporation and Rennova Health, Inc. ASSET PURCHASE AGREEMENT BY AND AMONG JELLICO community hospital, INC. AND CAREPLUS RURAL HEALTH CLINIC, LLC AND JELLICO MEDICAL CENTER, INC. AND COMMUNITY HOSPITAL CORPORATION AND RENNOVA HEALTH INC. November 20, 2018 TABLE OF CONTENTS Page 1. PURCHASE OF ASSETS 1 1.1 Assets 1 1.2 Excluded Assets 3 1.3 Assumed Liabilities 4 1.4 Excluded Liabilities 4 1.5 Purchase Price 6 1.6 Net Working Capital,
November 26, 2018	EX-99.1	rennova health ANNOUNCES DEFINITIVE AGREEMENT to acquire JELLICO COMMUNITY HOSPITAL, TENNESSEE rennova health ANNOUNCES DEFINITIVE AGREEMENT to acquire JELLICO COMMUNITY HOSPITAL, TENNESSEE WEST PALM BEACH, Fla.
November 21, 2018	PRE 14C	RNVA / Rennova Health, Inc. PRE 14C PRE 14C 1 formpre14c.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, For Use of the Commission Only (As Permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement RENNO
November 15, 2018	EX-99.1	Rennova Health reports THIRD quarter 2018 FINANCIAL RESULTS Rennova Health reports THIRD quarter 2018 FINANCIAL RESULTS WEST PALM BEACH, Fla. (November 15, 2018) – Rennova Health, Inc. (OTC: RNVAD), (OTC: RNVAW), (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that operates two rural hospitals in Tennessee, reports financial results for the three and ni
November 15, 2018	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 15, 2018 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission
November 14, 2018	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Material Modification to Rights of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 8, 2018 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
November 14, 2018	EX-3.19	Certificate of Amendment to Certificate of Incorporation of Rennova Health, Inc., filed November 9, 2018 (incorporated by reference to Exhibit 3.19 of the Company’s Current Report on Form 8-K filed with the SEC on November 14, 2018).
November 14, 2018	10-Q	RNVA / Rennova Health, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35141
November 9, 2018	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 9, 2018 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
November 9, 2018	EX-99.1	RENNOVA HEALTH, INC. ANNOUNCES FURTHER CHANGE IN EFFECTIVE DATE OF REVERSE STOCK SPLIT DUE TO FEDERAL HOLIDAY EX-99.1 2 ex99-1.htm RENNOVA HEALTH, INC. ANNOUNCES FURTHER CHANGE IN EFFECTIVE DATE OF REVERSE STOCK SPLIT DUE TO FEDERAL HOLIDAY WEST PALM BEACH, Fla. (November 9, 2018) – Rennova Health, Inc. (OTC: RNVA) (OTC: RNVAW), today announced that the effective time of the reverse split announced yesterday of 5:00 pm, Eastern Time, on November 9, 2018, has been moved to 5:00 pm, Eastern Time, on Novembe
November 8, 2018	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 8, 2018 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
November 8, 2018	EX-99.1	RENNOVA HEALTH, INC. ANNOUNCES CHANGE IN EFFECTIVE DATE OF REVERSE STOCK SPLIT EX-99.1 2 ex99-1.htm RENNOVA HEALTH, INC. ANNOUNCES CHANGE IN EFFECTIVE DATE OF REVERSE STOCK SPLIT WEST PALM BEACH, Fla. (November 8, 2018) – Rennova Health, Inc. (OTC: RNVA) (OTC: RNVAW), today announced that the effective day of the reverse split announced yesterday of 5:00 pm, Eastern Time, on November 8, 2018 (the “Effective Time”), has been moved to 5.00 pm, Eastern Time, on November 9, 2018
November 7, 2018	EX-99.1	RENNOVA HEALTH, INC. ANNOUNCES REVERSE STOCK SPLIT RENNOVA HEALTH, INC. ANNOUNCES REVERSE STOCK SPLIT WEST PALM BEACH, Fla. (November 7, 2018) – Rennova Health, Inc. (OTC: RNVA) (OTC: RNVAW), today announced that effective at 5:00 pm, Eastern Time, on November 8, 2018 (the “Effective Time”), the Company will effect a 1 for 500 reverse stock split of its outstanding common stock. The Company’s common stock will open for trading on Friday November 9
November 7, 2018	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 7, 2018 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F
October 16, 2018	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 16, 2018 Rennova Health, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35141 68-0370244 (Commission F

RNVA / Rennova Health, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)